Norway’s childhood cancer research landscape has taken a step forward with a record allocation of NOK 45.6 million in research funding announced by OCC member, the Norwegian Childhood Cancer Society (Barnekreftforeningen).
Cancer Crosslinks turns 18 years in 2026, making it one of the best-established cancer meeting series in Norway. This is what it looks like.
Kronikk. USA peker, kanskje ufrivillig, på noe viktig: Fremtidens legemiddelutvikling krever at flere bidrar, på flere måter enn bare gjennom pris.
We are pleased to introduce the newest members of our cluster, Barnekreftforeningen and BearingPoint.
Get to know the leading scientists and clinicians taking the stage at the new edition of Cancer Crosslinks.
Oslo Cancer Cluster, in collaboration with the Berlin Center for Gene and Cell Therapies, has published a new whitepaper titled “Bridging the Gaps: Unlocking the Future of Advanced Therapies in Europe via Novel Alliances.”
Get monthly news updates and invitations to events from our oncology cluster.
Stakeholders from across the Norwegian and European health innovation ecosystem gathered for the Oslo Deep Dive Days.
Photocure won the Norwegian Cancer Society Innovation Prize during the 10th anniversary celebration of Oslo Cancer Cluster Innovation Park.
During Oslo Cancer Cluster Innovations Park's 10th anniversary, the new John Ugelstad Building was officially opened.
Ber om tydeligere retning og smartere virkemidler.
Meet the newest members in our cluster.
A well-planned soft funding strategy can unleash a company's potential and help bring its idea to market faster.
